Thrombolysis for stroke

Archives of Neurology

Volumn 53, Issue 12, 1996, Pages 1305-1306

  Brott, Thomas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; STROKE;

EID: 0030448756     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550120117025     Document Type: Article

References (7)

1. Activase, Alteplase recombinant for acute ischemic stroke. Presented at the Peripheral and Central Nervous System Drug Advisory Committee Meeting; June 6, 1996; Bethesda, Md.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
3. Hacke W, Kaste M, Fieschi C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-1025.
4. Brott T, Haley EC, Levy DE, et al. Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
5. Haley EC, Levy DE, Brott TG, et al. Urgent therapy for stroke, il: pilot study of tissue plasminogen activator (rt-PA) administered 90-108 minutes from onset. Stroke. 1992;23:641-645.
6. del Zoppo G, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:7B-86.
7. Taylor TN, Davis PH, Torner JC, Holmes JS, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke. 1996;27:1459-1466.